The Natural History of Recovery After Stroke
Launched by ADI NEGEV-NAHALAT ERAN · Jun 1, 2024
Trial Information
Current as of February 19, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "The Natural History of Recovery After Stroke" is studying how people recover after experiencing a stroke. Researchers want to understand the changes in thinking (cognitive), movement (motor), and sensation (sensory) abilities over time in stroke patients. By observing patients as they recover, the study aims to provide valuable insights into the recovery process after a stroke.
To participate in this study, individuals must be at least 18 years old and should have been independent in daily activities before their stroke. The study is looking for people who have had their first stroke or a second stroke that didn’t make them disabled. Participants should be medically stable and able to give informed consent. Those with certain other medical conditions, such as severe neurological diseases or significant psychiatric issues, may not be eligible. If you join the study, you can expect to take part in regular assessments to monitor your recovery journey over time. This research could help improve understanding and support for stroke recovery in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • \>18 years of age
- • Independent in all activities of daily living before the stroke.
- • In- and out-patients at Adi-Negev Nahalat-Eran rehabilitation center, with first ever stroke, or with a recurrent stroke that did not lead to disability (were independent in ADL before the second stroke).
- • Medically stable
- • Able to provide informed consent.
- Exclusion Criteria:
- • The presence of any degenerative neurological condition, neuropathy, myopathy or Polio that are not secondary to stroke, excluding diabetic related changes.
- • Traumatic brain injury and/or extra-cerebral hemorrhage.
- • Significant psychiatric condition, including alcoholism and drug abuse.
- • Any severe orthopedic condition (such as amputation or severe pain that limits activity) or chronic pain syndrome.
- • Participation in another interventional study.
Trial Officials
Simona Bar-Haim, PhD
Principal Investigator
Ben-Gurion University of the Negev
Lior Smuelof, PhD
Principal Investigator
Ben-Gurion University of the Negev
Shirley Handelzalts, PhD
Principal Investigator
Ben-Gurion University of the Negev
Firas Mawase, PhD
Principal Investigator
Technion, Israel Institute of Technology
Akram Amro, PhD
Principal Investigator
Green Land Society for Health Development
About Adi Negev Nahalat Eran
Adi Negev-Nahalat Eran is a pioneering clinical trial sponsor dedicated to advancing innovative therapeutic solutions for individuals with complex neuropsychiatric conditions. With a strong commitment to research excellence and patient-centered care, the organization collaborates with leading academic institutions and healthcare providers to design and conduct rigorous clinical studies. Their focus on evidence-based approaches aims to enhance treatment outcomes and improve the quality of life for patients, while also contributing to the broader scientific community through the dissemination of research findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Haifa, , Israel
Ofakim, , Israel
Hebron, , Palestinian Territory, Occupied
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0